2A Biosciences (Seed)

Funding Details
Awarder
Gaingels
Date Award
July 02, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$14,250,000

Company Info
Founders
Alex Speiser
Company Description
A biotech aiming to revolutionize the treatment of inflammatory diseases with novel serotonin 5-HT2A agonists on a proprietary platform built to achieve anti-inflammatory efficacy at very low “micro” doses. 2A Biosciences is a pharmaceutical company that develops drugs with small molecules focusing on inflammation using 2A agonists.
Market
Healthcare & Wellness
Coinvestors
Lionheart Ventures,Palo Santo

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement